Literature DB >> 9460155

Contrast-enhanced magnetic resonance imaging in conservative management of lumbar disc herniation.

H Komori1, A Okawa, H Haro, T Muneta, H Yamamoto, K Shinomiya.   

Abstract

STUDY
DESIGN: This study was designed to investigate the morphologic changes in contrast-enhanced magnetic resonance imaging that occur during conservative treatment of patients with unilateral leg pain resulting from herniated nucleus pulposus without significant lumbar canal stenosis.
OBJECTIVES: To compare the morphologic results with clinical outcomes to ascertain whether enhanced magnetic resonance imaging contributes to the management of lumbar disc herniation. SUMMARY OF BACKGROUND DATA: Contrast-enhanced magnetic resonance imaging has already been reported to be useful in the postoperative examination of the lumbar spine and in visualization of symptomatic nerve roots. However, there have been few reports about its usefulness in the conservative management of herniated nucleus pulposus or about the correlation between herniated nucleus pulposus regression and enhanced effect. The study population consisted of 48 patients with radiculopathy. All patients primarily reported unilateral leg pain, and 94% had positive tension signs. Additionally, 38% exhibited muscle weakness corresponding to the symptomatic nerve root.
METHODS: All patients were studied twice or more using gadolinium-magnetic resonance imaging during conservative therapy, at a mean interval of 191 days. Changes in the size of the herniated nucleus pulposus on precontrast images fell into four categories, with changes in enhancement on postcontrast images classified into two categories: "enlargement" and "no change."
RESULTS: In all cases of migrating type herniated nucleus pulposus, circular enhancement was seen on postcontrast images. In 17 of 22 cases, the enhanced area gradually thickened and intruded into the migrated disc materials as the size of the herniated nucleus pulposus decreased; the herniated nucleus pulposus disappeared in nine cases and showed a marked decrease in seven cases. These cases showed good clinical courses of sciatica. In the other five patients, in whom there were no changes in the enhanced area, there was less of a tendency for the herniated nucleus pulposus to decrease in size, and there were poorer clinical results. In six cases of extruding-type herniated nucleus pulposus, no enhanced effects were observed throughout the follow-up period. The other 20 cases showed enhancement that was relatively weaker than that of migrating disc herniation. Extension or expansion of the enhanced area was observed in the follow-up images of 15 cases, though only four showed obvious changes in the size of the herniated nucleus pulposus. These 15 cases had better clinical results than the other cases, in which enhanced effects did not change or were not observed.
CONCLUSION: Contrast-enhanced magnetic resonance imaging is a useful prognostic parameter, and multiple use contributes to the proper management of lumbar disc herniation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9460155     DOI: 10.1097/00007632-199801010-00015

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  17 in total

1.  Spontaneous resolution of lumbar disk herniation: predictive signs for prognostic evaluation.

Authors:  Alessandra Splendiani; Edoardo Puglielli; Rosanna De Amicis; Antonio Barile; Carlo Masciocchi; Massimo Gallucci
Journal:  Neuroradiology       Date:  2004-11-11       Impact factor: 2.804

2.  Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption.

Authors:  H Haro; H C Crawford; B Fingleton; K Shinomiya; D M Spengler; L M Matrisian
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

3.  Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption.

Authors:  H Haro; H C Crawford; B Fingleton; J R MacDougall; K Shinomiya; D M Spengler; L M Matrisian
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

4.  Epidural corticosteroid injections for sciatica: a randomised, double blind, controlled clinical trial.

Authors:  J-P Valat; B Giraudeau; S Rozenberg; P Goupille; P Bourgeois; V Micheau-Beaugendre; M Soubrier; S Richard; E Thomas
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

5.  Evaluation of low back pain in athletes.

Authors:  James M Daniels; Gina Pontius; Saadiq El-Amin; Keith Gabriel
Journal:  Sports Health       Date:  2011-07       Impact factor: 3.843

6.  Acupuncture and spontaneous regression of a radiculopathic cervical herniated disc.

Authors:  Sung-Ha Kim; Man-Young Park; Sang-Mi Lee; Ho-Hyun Jung; Jae-Kyoun Kim; Jong-Deok Lee; Dong-Woung Kim; Seung-Ryong Yeom; Jin-Young Lim; Min-Jung Park; Se-Woon Park; Sung-Chul Kim
Journal:  J Pharmacopuncture       Date:  2012-06

7.  Timing of surgery for sciatica: subgroup analysis alongside a randomized trial.

Authors:  Wilco C Peul; Mark P Arts; Ronald Brand; Bart W Koes
Journal:  Eur Spine J       Date:  2009-01-09       Impact factor: 3.134

8.  The use of magnetic resonance imaging to predict the clinical outcome of non-surgical treatment for lumbar intervertebral disc herniation.

Authors:  Soo-Jung Choi; Jae Seok Song; Chunghwan Kim; Myung Jin Shin; Dae Sik Ryu; Jae Hong Ahn; Seung Moon Jung; Man Soo Park
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

Review 9.  Translational research of herniated discs: current status of diagnosis and treatment.

Authors:  Hirotaka Haro
Journal:  J Orthop Sci       Date:  2014-04-29       Impact factor: 1.601

10.  Long-Term Course to Lumbar Disc Resorption Patients and Predictive Factors Associated with Disc Resorption.

Authors:  Jinho Lee; Joowon Kim; Joon-Shik Shin; Yoon Jae Lee; Me-Riong Kim; Seon-Yeong Jeong; Young-Jun Choi; Tae Kyung Yoon; Byung-Heon Moon; Su-Bin Yoo; Jungsoo Hong; In-Hyuk Ha
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.